- Home
- HCI vs CGEM Comparison
HCI vs CGEM Comparison
Compare HCI & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCI
- CGEM
- Stock Information
- Founded
- HCI 2006
- CGEM 2016
- Country
- HCI United States
- CGEM United States
- Employees
- HCI N/A
- CGEM N/A
- Industry
- HCI Property-Casualty Insurers
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- HCI Finance
- CGEM Health Care
- Exchange
- HCI Nasdaq
- CGEM Nasdaq
- Market Cap
- HCI 1.2B
- CGEM 730.2M
- IPO Year
- HCI N/A
- CGEM 2021
- Fundamental
- Price
- HCI $114.75
- CGEM $12.62
- Analyst Decision
- HCI Buy
- CGEM Strong Buy
- Analyst Count
- HCI 5
- CGEM 7
- Target Price
- HCI $140.00
- CGEM $31.67
- AVG Volume (30 Days)
- HCI 120.9K
- CGEM 574.7K
- Earning Date
- HCI 11-07-2024
- CGEM 11-07-2024
- Dividend Yield
- HCI 1.37%
- CGEM N/A
- EPS Growth
- HCI 163.93
- CGEM N/A
- EPS
- HCI 11.94
- CGEM N/A
- Revenue
- HCI $750,846,000.00
- CGEM N/A
- Revenue This Year
- HCI N/A
- CGEM N/A
- Revenue Next Year
- HCI $14.52
- CGEM N/A
- P/E Ratio
- HCI $9.76
- CGEM N/A
- Revenue Growth
- HCI 48.73
- CGEM N/A
- 52 Week Low
- HCI $81.35
- CGEM $10.00
- 52 Week High
- HCI $126.50
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- HCI 54.49
- CGEM 50.78
- Support Level
- HCI $112.81
- CGEM $11.75
- Resistance Level
- HCI $119.73
- CGEM $12.85
- Average True Range (ATR)
- HCI 3.93
- CGEM 0.74
- MACD
- HCI 0.28
- CGEM 0.21
- Stochastic Oscillator
- HCI 76.23
- CGEM 89.64
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are HCPCI insurance operations, TypTap Group, Real estate operations, and Corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.